Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02126579
What this trial is testing

Phase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR Agonists

Who this might be right for
MelanomaMetastatic MelanomaMucosal Melanoma
Craig L Slingluff, Jr 50
Large-scale testing (Phase 3)Study completedNCT05297565
What this trial is testing

Compare Nivolumab Administered Subcutaneously vs Intravenous in Melanoma Participants Following Complete Resection

Who this might be right for
Melanoma
Bristol-Myers Squibb 14
Testing effectiveness (Phase 2)UnknownNCT01409733
What this trial is testing

TACE With Drug Eluting Beads Loaded With Doxorubicin in Liver Metastases From Melanoma Patients

Who this might be right for
Stage IV Melanoma Patients With Unresectable Liver Metastases
Heidelberg University 20
Testing effectiveness (Phase 2)Study completedNCT01335009
What this trial is testing

Efficacy Study of Pharmacokinetic(PK)/Pharmacodynamic(PD) Relationship of Monotherapy MORAb-004 in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Eisai Inc. 76
Testing effectiveness (Phase 2)Ended earlyNCT01543464
What this trial is testing

Peptide Vaccine and Temozolomide for Metastatic Melanoma Patients

Who this might be right for
Malignant Melanoma
Inge Marie Svane 41
Early research (Phase 1)Study completedNCT00412581
What this trial is testing

Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 28
Testing effectiveness (Phase 2)Study completedNCT00082914
What this trial is testing

Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)
National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT06444815
What this trial is testing

VET3-TGI in Patients With Solid Tumors

Who this might be right for
Solid Tumor, AdultMicrosatellite Stable Colorectal CancerHead and Neck Squamous Cell Carcinoma+10 more
KaliVir Immunotherapeutics 60
Testing effectiveness (Phase 2)Study completedNCT02363283
What this trial is testing

Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma

Who this might be right for
Recurrent Uveal MelanomaStage IV Uveal Melanoma AJCC v7
National Cancer Institute (NCI) 37
Early research (Phase 1)Study completedNCT00112229
What this trial is testing

Immunotherapy of HLA-A2 Positive Stage III/IV Melanoma Patients

Who this might be right for
Melanoma
Centre Hospitalier Universitaire Vaudois 29
Not applicableLooking for participantsNCT06075524
What this trial is testing

Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Lung Carcinoma+7 more
Mayo Clinic 500
Early research (Phase 1)Study completedNCT00085462
What this trial is testing

Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
National Institutes of Health Clinical Center (CC) 61
Early research (Phase 1)Study completedNCT01765569
What this trial is testing

A Pharmacokinetics Study to Investigate the Effect of Vemurafenib on Digoxin in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma

Who this might be right for
Malignant Melanoma, Neoplasms
Hoffmann-La Roche 29
Testing effectiveness (Phase 2)Study completedNCT01189383
What this trial is testing

IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma

Who this might be right for
Malignant Melanoma Stage IIIMalignant Melanoma Stage IV
Baylor Research Institute 20
Early research (Phase 1)Study completedNCT00085488
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Dartmouth-Hitchcock Medical Center
Early research (Phase 1)Study completedNCT01052142
What this trial is testing

Safety Study of a Liposomal Vaccine to Treat Malignant Melanoma

Who this might be right for
Melanoma
Lipotek Pty Ltd 12
Not applicableStudy completedNCT01960634
What this trial is testing

Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma

Who this might be right for
Stage IV Skin Melanoma
Grupo Español Multidisciplinar de Melanoma 58
Testing effectiveness (Phase 2)Study completedNCT00026221
What this trial is testing

Bevacizumab With or Without Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Recurrent MelanomaStage IV Skin Melanoma
National Cancer Institute (NCI) 57
Not applicableStudy completedNCT03493230
What this trial is testing

Detection of Plasmatic Cell-free BRAF and NRAS Mutations : a New Tool for Monitoring Patients With Metastatic Malignant Melanoma Treated With Targeted Therapies or Immunotherapy ( MALT )

Who this might be right for
Malignant Melanoma Stage IVMalignant Melanoma Stage III
Centre Hospitalier Universitaire de Nice 35
Large-scale testing (Phase 3)Study completedNCT00111007
What this trial is testing

A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Melanoma
Bayer 270
Next Page